Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Rare Disease Genetic Testing Market
2.1.1. Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS
2.1.2. Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing
2.1.3. Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT)
2.1.4. Global Rare Disease Genetic Testing Market, By Carrier Screening
2.1.5. Global Rare Disease Genetic Testing Market, By Diagnostic Testing
2.1.6. Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT)
2.1.7. Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing
2.1.8. Global Rare Disease Genetic Testing Market, By Technological Platforms
2.1.9. Global Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis
2.1.10. Global Rare Disease Genetic Testing Market, By End-User
2.1.11. Global Rare Disease Genetic Testing Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Rare Disease Genetic Testing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Rare Disease Genetic Testing Market Drivers
3.2.2. Rare Disease Genetic Testing Market Restraints
3.2.3. Rare Disease Genetic Testing Market Opportunities
3.2.4. Major Rare Disease Genetic Testing Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Next-Generation Sequencing (NGS
3.5.2. Targeted Genetic Testing
3.5.3. Non-Invasive Prenatal Testing (NIPT)
3.5.4. Carrier Screening
3.5.5. Diagnostic Testing
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Rare Disease Genetic Testing Market: Company Market Share, Value 2022
4.1.2. Global Rare Disease Genetic Testing Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Rare Disease Genetic Testing Market: Top 3 Company Market Share, Value 2022
4.2. Global Rare Disease Genetic Testing Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global Rare Disease Genetic Testing Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Plasma Protein Binding Studies in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Rare Disease Genetic Testing Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced Plasma Protein Binding Studies Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS
8.1. Global Rare Disease Genetic Testing Market Overview, By Next-Generation Sequencing (NGS
8.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Next-Generation Sequencing (NGS, 2022 Vs 2030 (in %)
8.2. Whole Genome Sequencing (WGS)
8.2.1. Global Rare Disease Genetic Testing Market, By WHOLE GENOME SEQUENCING (WGS), By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for WHOLE GENOME SEQUENCING (WGS)
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Whole Exome Sequencing (WES)
8.3.1. Global Rare Disease Genetic Testing Market, By Whole Exome Sequencing (WES), By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Whole Exome Sequencing (WES)
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing
9.1. Global Rare Disease Genetic Testing Market Overview, By Targeted Genetic Testing
9.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Targeted Genetic Testing, 2022 Vs 2030 (in %)
9.2. Panel Testing
9.2.1. Global Rare Disease Genetic Testing Market, By Panel Testing, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Panel Testing
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Single Gene Testing
9.3.1. Global Rare Disease Genetic Testing Market, By Single Gene Testing, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Single Gene Testing
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT)
10.1. Global Rare Disease Genetic Testing Market Overview, By Non-Invasive Prenatal Testing (NIPT)
10.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Non-Invasive Prenatal Testing (NIPT), 2022 Vs 2030 (in %)
10.2. Screening for Genetic Disorders in the Fetus
10.2.1. Global Rare Disease Genetic Testing Market, By Screening for Genetic Disorders in the Fetus, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Screening for Genetic Disorders in the Fetus
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
11. Global Rare Disease Genetic Testing Market, By Carrier Screening
11.1. Global Rare Disease Genetic Testing Market Overview, by Carrier Screening
11.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Carrier Screening, 2022 Vs 2030 (in %)
11.2. Identifying Carriers of Genetic Mutations
11.2.1. Global Rare Disease Genetic Testing Market, By Identifying Carriers of Genetic Mutations, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Identifying Carriers of Genetic Mutations
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
12. Global Rare Disease Genetic Testing Market, By Diagnostic Testing
12.1. Global Rare Disease Genetic Testing Market Overview, By Diagnostic Testing
12.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Diagnostic Testing, 2022 Vs 2030 (in %)
12.2. Confirmatory Testing
12.2.1. Global Rare Disease Genetic Testing Market, By Confirmatory Testing, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Confirmatory Testing
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Comprehensive Diagnostic Testing
12.3.1. Global Rare Disease Genetic Testing Market, By Comprehensive Diagnostic Testing, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Comprehensive Diagnostic Testing
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT)
13.1. Global Rare Disease Genetic Testing Market Overview, By Preimplantation Genetic Testing (PGT)
13.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Preimplantation Genetic Testing (PGT), 2022 Vs 2030 (in %)
13.2. Screening Embryos for Genetic Abnormalities
13.2.1. Global Rare Disease Genetic Testing Market, By Screening Embryos for Genetic Abnormalities, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Screening Embryos for Genetic Abnormalities
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
14. Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing
14.1. Global Rare Disease Genetic Testing Market Overview, By Direct-to-Consumer (DTC) Genetic Testing
14.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Direct-to-Consumer (DTC) Genetic Testing, 2022 Vs 2030 (in %)
14.2. Consumer-Initiated Genetic Testing Services
14.2.1. Global Rare Disease Genetic Testing Market, By Consumer-Initiated Genetic Testing Services, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Consumer-Initiated Genetic Testing Services
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
15. Global Rare Disease Genetic Testing Market, By Technological Platforms
15.1. Global Rare Disease Genetic Testing Market Overview, By Technological Platforms
15.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Technological Platforms, 2022 Vs 2030 (in %)
15.2. Microarray Technology
15.2.1. Global Rare Disease Genetic Testing Market, By Microarray Technology, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Microarray Technology
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Microarray PCR (Polymerase Chain Reaction)
15.3.1. Global Rare Disease Genetic Testing Market, By Microarray PCR (Polymerase Chain Reaction), By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Microarray PCR (Polymerase Chain Reaction)
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis
16.1. Global Rare Disease Genetic Testing Market Overview, By Bioinformatics and Data Analysis
16.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By Bioinformatics and Data Analysis, 2022 Vs 2030 (in %)
16.2. Interpretation Services
16.2.1. Global Rare Disease Genetic Testing Market, By Interpretation Services, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Interpretation Services
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. Data Storage and Management
16.3.1. Global Rare Disease Genetic Testing Market, By Data Storage and Management, By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for Data Storage and Management
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
17. Global Rare Disease Genetic Testing Market, By End-User
17.1. Global Rare Disease Genetic Testing Market Overview, By End-User
17.1.1. Global Rare Disease Genetic Testing Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
17.2. Hospitals and Clinics
17.2.1. Global Rare Disease Genetic Testing Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Hospitals and Clinics
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
17.3. Genetic Testing Laboratories
17.3.1. Global Rare Disease Genetic Testing Market, By Genetic Testing Laboratories, By Region, 2017-2030 (US$ Mn)
17.3.2. Market Dynamics for Genetic Testing Laboratories
17.3.2.1. Drivers
17.3.2.2. Restraints
17.3.2.3. Opportunities
17.3.2.4. Trends
17.4. Direct-to-Consumer Companies
17.4.1. Global Rare Disease Genetic Testing Market, By Direct-to-Consumer Companies, By Region, 2017-2030 (US$ Mn)
17.4.2. Market Dynamics for Direct-to-Consumer Companies
17.4.2.1. Drivers
17.4.2.2. Restraints
17.4.2.3. Opportunities
17.4.2.4. Trends
18. Global Rare Disease Genetic Testing Market, By Region
18.1. Global Rare Disease Genetic Testing Market Overview, by Region
18.1.1. Global Rare Disease Genetic Testing Market, By Region, 2022 vs 2030 (in%)
18.2. Next-Generation Sequencing (NGS
18.2.1. Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030 (US$ Mn)
18.3. Targeted Genetic Testing
18.3.1. Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030 (US$ Mn)
18.4. Non-Invasive Prenatal Testing (NIPT)
18.4.1. Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030 (US$ Mn)
18.5. Carrier Screening
18.5.1. Global Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030 (US$ Mn)
18.6. Diagnostic Testing
18.6.1. Global Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030 (US$ Mn)
18.7. Preimplantation Genetic Testing (PGT)
18.7.1. Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030 (US$ Mn)
18.8. Direct-to-Consumer (DTC) Genetic Testing
18.8.1. Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030 (US$ Mn)
18.9. Technological Platforms
18.9.1. Global Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030 (US$ Mn)
18.10. Bioinformatics and Data Analysis
18.10.1. Global Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030 (US$ Mn)
18.11. End-User
18.11.1. Global Rare Disease Genetic Testing Market, By End-User, 2017-2030 (US$ Mn)
19. North America Rare Disease Genetic Testing Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. North America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. North America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. North America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. North America Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. North America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. North America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. North America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. North America Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. North America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
19.10.1. Overview
19.10.2. SRC Analysis
19.11. North America Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
19.11.1. Overview
19.11.2. SRC Analysis
19.12. North America Rare Disease Genetic Testing Market, by Country, 2017-2030(US$ Mn)
19.12.1. North America Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
19.12.2. U.S.
19.12.3. Canada
19.12.4. Mexico
20. Europe Rare Disease Genetic Testing Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Europe Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Europe Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Europe Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Europe Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Europe Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Europe Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Europe Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Europe Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
20.10.1. Overview
20.10.2. SRC Analysis
20.11. Europe Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
20.11.1. Overview
20.11.2. SRC Analysis
20.12. Europe Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
20.12.1. Europe Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
20.12.2. UK
20.12.3. France
20.12.4. Germany
20.12.5. Italy
20.12.6. Spain
20.12.7. Benelux
20.12.8. Russia
20.12.9. Rest of Europe
21. Asia Pacific Rare Disease Genetic Testing Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Asia Pacific Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Asia Pacific Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Asia Pacific Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Asia Pacific Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Asia Pacific Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Asia Pacific Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Asia Pacific Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. Asia Pacific Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
21.11.1. Overview
21.11.2. SRC Analysis
21.12. Asia Pacific Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
21.12.1. Asia Pacific Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
21.12.2. China
21.12.3. Japan
21.12.4. India
21.12.5. South Korea
21.12.6. South East Asia
21.12.7. Rest of Asia Pacific
22. Latin America Rare Disease Genetic Testing Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Latin America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Latin America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Latin America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Latin America Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Latin America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Latin America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Latin America Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Latin America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Latin America Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
22.11.1. Overview
22.11.2. SRC Analysis
22.12. Latin America Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
22.12.1. Latin America Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
22.12.2. Brazil
22.12.3. Argentina
22.12.4. Rest of Latin America
23. Middle East Rare Disease Genetic Testing Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Middle East Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Middle East Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Middle East Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Middle East Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Middle East Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Middle East Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
23.11.1. Overview
23.11.2. SRC Analysis
23.12. Middle East Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
23.12.1. Middle East Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
23.12.2. UAE
23.12.3. Saudi Arabia
23.12.4. Rest of Middle East
24. Africa Rare Disease Genetic Testing Market Analysis
24.1. Overview
24.1.1. Market Dynamics for North America
24.1.1.1. Drivers
24.1.1.2. Restraints
24.1.1.3. Opportunities
24.1.1.4. Trends
24.2. Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2030(US$ Mn)
24.2.1. Overview
24.2.2. SRC Analysis
24.3. Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2030(US$ Mn)
24.3.1. Overview
24.3.2. SRC Analysis
24.4. Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2030(US$ Mn)
24.4.1. Overview
24.4.2. SRC Analysis
24.5. Africa Rare Disease Genetic Testing Market, By Carrier Screening, 2017-2030(US$ Mn)
24.5.1. Overview
24.5.2. SRC Analysis
24.6. Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2030(US$ Mn)
24.6.1. Overview
24.6.2. SRC Analysis
24.7. Africa Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2030(US$ Mn)
24.7.1. Overview
24.7.2. SRC Analysis
24.8. Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2030(US$ Mn)
24.8.1. Overview
24.8.2. SRC Analysis
24.9. Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2030(US$ Mn)
24.9.1. Overview
24.9.2. SRC Analysis
24.10. Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, 2017-2030(US$ Mn)
24.10.1. Overview
24.10.2. SRC Analysis
24.11. Africa Rare Disease Genetic Testing Market, By End-User, 2017-2030(US$ Mn)
24.11.1. Overview
24.11.2. SRC Analysis
24.12. Africa Rare Disease Genetic Testing Market, by Country, 2017-2030 (US$ Mn)
24.12.1. Middle East Rare Disease Genetic Testing Market, by Country, 2022 Vs 2030 (in%)
24.12.2. South Africa
24.12.3. Egypt
24.12.4. Rest of Africa
25. Company Profiles
25.1. Quest Diagnostics, Inc.
25.1.1. Company Overview
25.1.2. Types/Services Portfolio
25.1.3. Geographical Presence
25.1.4. SWOT Analysis
25.1.5. Financial Summary
25.1.5.1. Market Revenue and Net Profit (2019-2022)
25.1.5.2. Business Segment Revenue Analysis
25.1.5.3. Geographical Revenue Analysis
25.2. Centogene N.V.
25.3. Invitae Corp.
25.4. 3billion, Inc.
25.5. Arup Laboratories
25.6. Eurofins Scientific
25.7. Strand Life Sciences
25.8. Ambry Genetics
25.9. Perkin Elmer, Inc.
25.10. Macrogen, Inc.
25.11. Baylor Genetics
25.12. Color Genomics, Inc.
25.13. Health Network Laboratories
25.14. PreventionGenetics
25.15. Progenity, Inc.
25.16. Coopersurgical, Inc.
25.17. Fulgent Genetics Inc.
25.18. Myriad Genetics, Inc.
25.19. Laboratory Corporation Of America Holdings
25.20. Opko Health, Inc.
25.21. Artemis DNA
26. Research Methodology
26.1. Research Methodology
26.2. Screening for Genetic Disorders in the Fetus – Secondary Research
26.3. Screening for Genetic Disorders in the FetusI – Data Modelling
26.3.1. Company Share Analysis Model
26.3.2. Revenue Based Modelling
26.4. Screening for Genetic Disorders in the FetusII – Primary Research
26.5. Research Limitations
26.5.1. Assumptions
List of Figures
FIG. 1 Global Rare Disease Genetic Testing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Rare Disease Genetic Testing Market Segmentation
FIG. 4 Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2022 (US$ Mn)
FIG. 5 Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2022 (US$ Mn)
FIG. 6 Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2022 (US$ Mn)
FIG. 7 Global Rare Disease Genetic Testing Market, by Carrier Screening, 2022 (US$ Mn)
FIG. 8 Global Rare Disease Genetic Testing Market, By Diagnostic Testing, 2022 (US$ Mn)
FIG. 9 Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2022 (US$ Mn)
FIG. 10 Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2022 (US$ Mn)
FIG. 11 Global Rare Disease Genetic Testing Market, By Technological Platforms, 2022 (US$ Mn)
FIG. 12 Global Rare Disease Genetic Testing Market, by Bioinformatics and Data Analysis, 2022 (US$ Mn)
FIG. 13 Global Rare Disease Genetic Testing Market, By End-User, 2022 (US$ Mn)
FIG. 14 Global Rare Disease Genetic Testing Market, by Geography, 2022 (US$ Mn)
FIG. 15 Attractive Investment Proposition, By Next-Generation Sequencing (NGS, 2022
FIG. 16 Attractive Investment Proposition, By Targeted Genetic Testing, 2022
FIG. 17 Attractive Investment Proposition, By Non-Invasive Prenatal Testing (NIPT), 2022
FIG. 18 Attractive Investment Proposition, By Carrier Screening, 2022
FIG. 19 Attractive Investment Proposition, By Diagnostic Testing, 2022
FIG. 20 Attractive Investment Proposition, By Preimplantation Genetic Testing (PGT), 2022
FIG. 21 Attractive Investment Proposition, By Direct-to-Consumer (DTC) Genetic Testing, 2022
FIG. 22 Attractive Investment Proposition, By Technological Platforms, 2022
FIG. 23 Attractive Investment Proposition, By Bioinformatics and Data Analysis, 2022
FIG. 24 Attractive Investment Proposition, By End-User, 2022
FIG. 25 Attractive Investment Proposition, by Geography, 2022
FIG. 26 Global Market Share Analysis of Key Rare Disease Genetic Testing Market Manufacturers, 2022
FIG. 27 Global Market Positioning of Key Rare Disease Genetic Testing Market Manufacturers, 2022
FIG. 28 Global Rare Disease Genetic Testing Market Value Contribution, By Next-Generation Sequencing (NGS, 2022 & 2030 (Value %)
FIG. 29 Global Rare Disease Genetic Testing Market, by WHOLE GENOME SEQUENCING (WGS), Value, 2017-2030 (US$ Mn)
FIG. 30 Global Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), Value, 2017-2030 (US$ Mn)
FIG. 31 Global Rare Disease Genetic Testing Market Value Contribution, By Targeted Genetic Testing, 2022 & 2030 (Value %)
FIG. 32 Global Rare Disease Genetic Testing Market, by Panel Testing, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Rare Disease Genetic Testing Market, by Single Gene Testing, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Rare Disease Genetic Testing Market Value Contribution, By Non-Invasive Prenatal Testing (NIPT), 2022 & 2030 (Value %)
FIG. 35 Global Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Rare Disease Genetic Testing Market Value Contribution, By Carrier Screening, 2022 & 2030 (Value %)
FIG. 37 Global Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Rare Disease Genetic Testing Market Value Contribution, By Diagnostic Testing, 2022 & 2030 (Value %)
FIG. 39 Global Rare Disease Genetic Testing Market, by Confirmatory Testing, Value, 2017-2030 (US$ Mn)
FIG. 40 Global Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, Value, 2017-2030 (US$ Mn)
FIG. 41 Global Rare Disease Genetic Testing Market Value Contribution, By Preimplantation Genetic Testing (PGT), 2022 & 2030 (Value %)
FIG. 42 Global Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, Value, 2017-2030 (US$ Mn)
FIG. 43 Global Rare Disease Genetic Testing Market Value Contribution, By Direct-to-Consumer (DTC) Genetic Testing, 2022 & 2030 (Value %)
FIG. 44 Global Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, Value, 2017-2030 (US$ Mn)
FIG. 45 Global Rare Disease Genetic Testing Market Value Contribution, By Technological Platforms, 2022 & 2030 (Value %)
FIG. 46 Global Rare Disease Genetic Testing Market, by Microarray Technology, Value, 2017-2030 (US$ Mn)
FIG. 47 Global Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), Value, 2017-2030 (US$ Mn)
FIG. 48 Global Rare Disease Genetic Testing Market Value Contribution, By Bioinformatics and Data Analysis, 2022 & 2030 (Value %)
FIG. 49 Global Rare Disease Genetic Testing Market, by Interpretation Services, Value, 2017-2030 (US$ Mn)
FIG. 50 Global Rare Disease Genetic Testing Market, by Data Storage and Management, Value, 2017-2030 (US$ Mn)
FIG. 51 Global Rare Disease Genetic Testing Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 52 Global Rare Disease Genetic Testing Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 53 Global Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, Value, 2017-2030 (US$ Mn)
FIG. 54 Global Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, Value, 2017-2030 (US$ Mn)
FIG. 55 Global Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, Value, 2017-2030 (US$ Mn)
FIG. 56 North America Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 57 U.S. Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 58 Canada Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 59 Mexico Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 60 Europe Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 61 Germany Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 62 France Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 63 U.K. Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 64 Italy Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 65 Spain Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 66 Benelux Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 67 Russia Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 68 Rest of Europe Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 69 Asia Pacific Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 70 China Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 71 Japan Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 72 India Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 73 South Korea Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 74 South-East Asia Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 75 Rest of Asia Pacific Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 76 Latin America Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 77 Brazil Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 78 Argentina Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 79 Rest of Latin America Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 80 Middle East Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 81 UAE Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 82 Saudi Arabia Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 83 Rest of Middle East Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 84 Africa Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 85 South Africa Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 86 Egypt Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
FIG. 87 Rest of Africa Rare Disease Genetic Testing Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Rare Disease Genetic Testing Market
TABLE 2 Global Rare Disease Genetic Testing Market: Drivers Impact Analysis
TABLE 3 Global Rare Disease Genetic Testing Market: Market Restraints Impact Analysis
TABLE 4 Global Rare Disease Genetic Testing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Rare Disease Genetic Testing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Rare Disease Genetic Testing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Rare Disease Genetic Testing Market, by Whole Genome Sequencing (WGS), By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Rare Disease Genetic Testing Market, by Whole Genome Sequencing (WGS), By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Rare Disease Genetic Testing Market, by Whole Exome Sequencing (WES), By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Rare Disease Genetic Testing Market, by Panel Testing, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Rare Disease Genetic Testing Market, by Panel Testing, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Rare Disease Genetic Testing Market, by Single Gene Testing, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Rare Disease Genetic Testing Market, by Single Gene Testing, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Rare Disease Genetic Testing Market, by Screening for Genetic Disorders in the Fetus, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Rare Disease Genetic Testing Market, by Identifying Carriers of Genetic Mutations, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Rare Disease Genetic Testing Market, by Confirmatory Testing, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Rare Disease Genetic Testing Market, by Confirmatory Testing, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Rare Disease Genetic Testing Market, by Comprehensive Diagnostic Testing, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Rare Disease Genetic Testing Market, by Screening Embryos for Genetic Abnormalities, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Rare Disease Genetic Testing Market, by Consumer-Initiated Genetic Testing Services, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Rare Disease Genetic Testing Market, by Microarray Technology, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Rare Disease Genetic Testing Market, by Microarray Technology, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Rare Disease Genetic Testing Market, by Microarray PCR (Polymerase Chain Reaction), By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Rare Disease Genetic Testing Market, by Interpretation Services, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Rare Disease Genetic Testing Market, by Interpretation Services, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Rare Disease Genetic Testing Market, by Data Storage and Management, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Rare Disease Genetic Testing Market, by Data Storage and Management, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Rare Disease Genetic Testing Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Rare Disease Genetic Testing Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Rare Disease Genetic Testing Market, by Genetic Testing Laboratories, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Rare Disease Genetic Testing Market, by Direct-to-Consumer Companies, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Rare Disease Genetic Testing Market, by Compliance with Regulatory Standards, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Rare Disease Genetic Testing Market, by Compliance with Regulatory Standards, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Rare Disease Genetic Testing Market, by Industry and Academic Collaborations, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 46 Global Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 47 Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 48 Global Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 49 Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 50 Global Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 51 Global Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 52 Global Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 53 Global Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 54 Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 55 Global Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 56 Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 57 Global Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 58 Global Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 59 Global Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 60 Global Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 61 Global Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 62 Global Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 63 Global Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 64 Global Rare Disease Genetic Testing Market, by Region, 2017-2022 (US$ Mn)
TABLE 65 Global Rare Disease Genetic Testing Market, by Region, 2023-2030 (US$ Mn)
TABLE 66 North America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 67 North America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 68 North America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 69 North America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 70 North America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 71 North America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 72 North America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 73 North America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 74 North America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 75 North America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 76 North America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 77 North America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 78 North America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 79 North America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 80 North America Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 81 North America Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 82 North America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 83 North America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 84 North America Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 85 North America Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 86 North America Rare Disease Genetic Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 87 North America Rare Disease Genetic Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 88 United States Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 89 United States Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 90 United States Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 91 United States Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 92 United States Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 93 United States Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 94 United States Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 95 United States Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 96 United States Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 97 United States Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 98 United States Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 99 United States Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 100 United States Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 101 United States Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 102 United States Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 103 United States Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 104 United States Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 105 United States Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 106 United States Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 107 United States Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 108 Canada Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 109 Canada Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 110 Canada Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 111 Canada Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 112 Canada Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 113 Canada Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 114 Canada Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 115 Canada Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 116 Canada Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 117 Canada Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 118 Canada Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 119 Canada Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 120 Canada Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 121 Canada Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 122 Canada Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 123 Canada Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 124 Canada Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 125 Canada Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 126 Canada Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 127 Canada Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 128 Mexico Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 129 Mexico Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 130 Mexico Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 131 Mexico Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 132 Mexico Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 133 Mexico Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 134 Mexico Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 135 Mexico Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 136 Mexico Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 137 Mexico Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 138 Mexico Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 139 Mexico Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 140 Mexico Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 141 Mexico Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 142 Mexico Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 143 Mexico Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 144 Mexico Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 145 Mexico Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 146 Mexico Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 147 Mexico Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 148 Europe Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 149 Europe Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 150 Europe Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 151 Europe Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 152 Europe Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 153 Europe Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 154 Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 155 Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 156 Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 157 Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 158 Europe Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 159 Europe Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 160 Europe Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 161 Europe Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 162 Europe Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 163 Europe Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 164 Europe Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 165 Europe Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 166 Europe Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 167 Europe Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 168 Europe Rare Disease Genetic Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 169 Europe Rare Disease Genetic Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 170 Germany Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 171 Germany Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 172 Germany Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 173 Germany Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 174 Germany Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 175 Germany Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 176 Germany Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 177 Germany Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 178 Germany Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 179 Germany Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 180 Germany Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 181 Germany Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 182 Germany Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 183 Germany Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 184 Germany Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 185 Germany Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 186 Germany Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 187 Germany Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 188 Germany Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 189 Germany Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 190 France Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 191 France Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 192 France Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 193 France Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 194 France Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 195 France Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 196 France Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 197 France Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 198 France Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 199 France Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 200 France Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 201 France Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 202 France Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 203 France Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 204 France Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 205 France Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 206 France Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 207 France Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 208 France Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 209 France Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 210 United Kingdom Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 211 United Kingdom Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 212 United Kingdom Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 213 United Kingdom Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 214 United Kingdom Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 215 United Kingdom Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 216 United Kingdom Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 217 United Kingdom Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 218 United Kingdom Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 219 United Kingdom Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 220 United Kingdom Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 221 United Kingdom Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 222 United Kingdom Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 223 United Kingdom Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 224 United Kingdom Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 225 United Kingdom Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 226 United Kingdom Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 227 United Kingdom Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 228 United Kingdom Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 229 United Kingdom Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 230 Italy Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 231 Italy Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 232 Italy Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 233 Italy Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 234 Italy Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 235 Italy Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 236 Italy Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 237 Italy Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 238 Italy Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 239 Italy Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 240 Italy Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 241 Italy Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2023-2030 (US$ Mn)
TABLE 242 Italy Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 243 Italy Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 244 Italy Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 245 Italy Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 246 Italy Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 247 Italy Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 248 Italy Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 249 Italy Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 250 Spain Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 251 Spain Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 252 Spain Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 253 Spain Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 254 Spain Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 255 Spain Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 256 Spain Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 257 Spain Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 258 Spain Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 259 Spain Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 260 Spain Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 261 Spain Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 262 Spain Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 263 Spain Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 264 Spain Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 265 Spain Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 266 Spain Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 267 Spain Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 268 Spain Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 269 Spain Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 270 Benelux Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 271 Benelux Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 272 Benelux Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 273 Benelux Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 274 Benelux Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 275 Benelux Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 276 Benelux Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 277 Benelux Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 278 Benelux Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 279 Benelux Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 280 Benelux Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 281 Benelux Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 282 Benelux Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 283 Benelux Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 284 Benelux Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 285 Benelux Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 286 Benelux Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 287 Benelux Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 288 Benelux Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 289 Benelux Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 290 Russia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 291 Russia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 292 Russia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 293 Russia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 294 Russia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 295 Russia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 296 Russia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 297 Russia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 298 Russia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 299 Russia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 300 Russia Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 301 Russia Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 302 Russia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 303 Russia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 304 Russia Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 305 Russia Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 306 Russia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 307 Russia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 308 Russia Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 309 Russia Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 310 Rest of Europe Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 311 Rest of Europe Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 312 Rest of Europe Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 313 Rest of Europe Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 314 Rest of Europe Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 315 Rest of Europe Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 316 Rest of Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 317 Rest of Europe Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 318 Rest of Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 319 Rest of Europe Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 320 Rest of Europe Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 321 Rest of Europe Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 322 Rest of Europe Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 323 Rest of Europe Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 324 Rest of Europe Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 325 Rest of Europe Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 326 Rest of Europe Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 327 Rest of Europe Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 328 Rest of Europe Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 329 Rest of Europe Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 330 Asia Pacific Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 331 Asia Pacific Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 332 Asia Pacific Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 333 Asia Pacific Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 334 Asia Pacific Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 335 Asia Pacific Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 336 Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 337 Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 338 Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 339 Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 340 Asia Pacific Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 341 Asia Pacific Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 342 Asia Pacific Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 343 Asia Pacific Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 344 Asia Pacific Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 345 Asia Pacific Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 346 Asia Pacific Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 347 Asia Pacific Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 348 Asia Pacific Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 349 Asia Pacific Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 350 China Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 351 China Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 352 China Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 353 China Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 354 China Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 355 China Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 356 China Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 357 China Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 358 China Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 359 China Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 360 China Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 361 China Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 362 China Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 363 China Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 364 China Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 365 China Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 366 China Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 367 China Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 368 China Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 369 China Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 370 Japan Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 371 Japan Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 372 Japan Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 373 Japan Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 374 Japan Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 375 Japan Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 376 Japan Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 377 Japan Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 378 Japan Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 379 Japan Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 380 Japan Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 381 Japan Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 382 Japan Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 383 Japan Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 384 Japan Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 385 Japan Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 386 Japan Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 387 Japan Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 388 Japan Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 389 Japan Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 390 India Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 391 India Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 392 India Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 393 India Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 394 India Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 395 India Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 396 India Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 397 India Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 398 India Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 399 India Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 400 India Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 401 India Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 402 India Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 403 India Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 404 India Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 405 India Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 406 India Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 407 India Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 408 India Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 409 India Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 410 South Korea Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 411 South Korea Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 412 South Korea Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 413 South Korea Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 414 South Korea Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 415 South Korea Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 416 South Korea Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 417 South Korea Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 418 South Korea Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 419 South Korea Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 420 South Korea Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 421 South Korea Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 422 South Korea Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 423 South Korea Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 424 South Korea Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 425 South Korea Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 426 South Korea Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 427 South Korea Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 428 South Korea Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 429 South Korea Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 430 South-East Asia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 431 South-East Asia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 432 South-East Asia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 433 South-East Asia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 434 South-East Asia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 435 South-East Asia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 436 South-East Asia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 437 South-East Asia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 438 South-East Asia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 439 South-East Asia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 440 South-East Asia Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 441 South-East Asia Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 442 South-East Asia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 443 South-East Asia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 444 South-East Asia Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 445 South-East Asia Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 446 South-East Asia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 447 South-East Asia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 448 South-East Asia Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 449 South-East Asia Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 450 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 451 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 452 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 453 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 454 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 455 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 456 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 457 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 458 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 459 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 460 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 461 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 462 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 463 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 464 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 465 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 466 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 467 Rest of Asia Pacific Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 468 Rest of Asia Pacific Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 469 Rest of Asia Pacific Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 470 Latin America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 471 Latin America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 472 Latin America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 473 Latin America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 474 Latin America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 475 Latin America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 476 Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 477 Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 478 Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 479 Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 480 Latin America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 481 Latin America Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 482 Latin America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 483 Latin America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 484 Latin America Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 485 Latin America Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 486 Latin America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 487 Latin America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 488 Latin America Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 489 Latin America Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 490 Brazil Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 491 Brazil Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 492 Brazil Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 493 Brazil Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 494 Brazil Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 495 Brazil Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 496 Brazil Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 497 Brazil Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 498 Brazil Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 499 Brazil Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 500 Brazil Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 501 Brazil Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 502 Brazil Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 503 Brazil Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 504 Brazil Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 505 Brazil Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 506 Brazil Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 507 Brazil Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 508 Brazil Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 509 Brazil Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 510 Argentina Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 511 Argentina Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 512 Argentina Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 513 Argentina Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 514 Argentina Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 515 Argentina Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 516 Argentina Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 517 Argentina Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 518 Argentina Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 519 Argentina Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 520 Argentina Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 521 Argentina Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 522 Argentina Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 523 Argentina Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 524 Argentina Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 525 Argentina Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 526 Argentina Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 527 Argentina Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 528 Argentina Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 529 Argentina Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 530 Rest of Latin America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 531 Rest of Latin America Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 532 Rest of Latin America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 533 Rest of Latin America Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 534 Rest of Latin America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 535 Rest of Latin America Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 536 Rest of Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 537 Rest of Latin America Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 538 Rest of Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 539 Rest of Latin America Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 540 Rest of Latin America Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 541 Rest of Latin America Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 542 Rest of Latin America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 543 Rest of Latin America Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 544 Rest of Latin America Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 545 Rest of Latin America Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 546 Rest of Latin America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 547 Rest of Latin America Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 548 Rest of Latin America Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 549 Rest of Latin America Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 550 Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 551 Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 552 Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 553 Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 554 Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 555 Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 556 Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 557 Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 558 Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 559 Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 560 Middle East Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 561 Middle East Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 562 Middle East Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 563 Middle East Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 564 Middle East Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 565 Middle East Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 566 Middle East Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 567 Middle East Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 568 Middle East Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 569 Middle East Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 570 UAE Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 571 UAE Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 572 UAE Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 573 UAE Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 574 UAE Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 575 UAE Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 576 UAE Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 577 UAE Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 578 UAE Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 579 UAE Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 580 UAE Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 581 UAE Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 582 UAE Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 583 UAE Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 584 UAE Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 585 UAE Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 586 UAE Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 587 UAE Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 588 UAE Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 589 UAE Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 590 Saudi Arabia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 591 Saudi Arabia Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 592 Saudi Arabia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 593 Saudi Arabia Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 594 Saudi Arabia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 595 Saudi Arabia Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 596 Saudi Arabia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 597 Saudi Arabia Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 598 Saudi Arabia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 599 Saudi Arabia Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 600 Saudi Arabia Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 601 Saudi Arabia Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 602 Saudi Arabia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 603 Saudi Arabia Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 604 Saudi Arabia Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 605 Saudi Arabia Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 606 Saudi Arabia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 607 Saudi Arabia Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 608 Saudi Arabia Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 609 Saudi Arabia Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 610 Rest of Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 611 Rest of Middle East Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 612 Rest of Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 613 Rest of Middle East Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 614 Rest of Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 615 Rest of Middle East Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 616 Rest of Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 617 Rest of Middle East Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 618 Rest of Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 619 Rest of Middle East Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 620 Rest of Middle East Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 621 Rest of Middle East Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 622 Rest of Middle East Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 623 Rest of Middle East Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 624 Rest of Middle East Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 625 Rest of Middle East Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 626 Rest of Middle East Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 627 Rest of Middle East Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 628 Rest of Middle East Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 629 Rest of Middle East Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 630 Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 631 Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 632 Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 633 Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 634 Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 635 Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 636 Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 637 Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 638 Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 639 Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 640 Africa Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 641 Africa Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 642 Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 643 Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 644 Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 645 Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 646 Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 647 Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 648 Africa Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 649 Africa Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 650 South Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 651 South Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 652 South Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 653 South Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 654 South Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 655 South Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 656 South Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 657 South Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 658 South Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 659 South Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 660 South Africa Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 661 South Africa Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 662 South Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 663 South Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 664 South Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 665 South Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 666 South Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 667 South Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 668 South Africa Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 669 South Africa Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 670 Egypt Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 671 Egypt Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 672 Egypt Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 673 Egypt Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 674 Egypt Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 675 Egypt Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 676 Egypt Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 677 Egypt Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 678 Egypt Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 679 Egypt Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 680 Egypt Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 681 Egypt Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 682 Egypt Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 683 Egypt Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 684 Egypt Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 685 Egypt Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 686 Egypt Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 687 Egypt Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 688 Egypt Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)
TABLE 689 Egypt Rare Disease Genetic Testing Market, By End-User, 2023-2030 (US$ Mn)
TABLE 690 Rest of Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2017-2022 (US$ Mn)
TABLE 691 Rest of Africa Rare Disease Genetic Testing Market, By Next-Generation Sequencing (NGS, 2023-2030 (US$ Mn)
TABLE 692 Rest of Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2017-2022 (US$ Mn)
TABLE 693 Rest of Africa Rare Disease Genetic Testing Market, By Targeted Genetic Testing, 2023-2030 (US$ Mn)
TABLE 694 Rest of Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2017-2022 (US$ Mn)
TABLE 695 Rest of Africa Rare Disease Genetic Testing Market, By Non-Invasive Prenatal Testing (NIPT), 2023-2030 (US$ Mn)
TABLE 696 Rest of Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2017-2022 (US$ Mn)
TABLE 697 Rest of Africa Rare Disease Genetic Testing Market, By Carrier Screening, By Region, 2023-2030 (US$ Mn)
TABLE 698 Rest of Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2017-2022 (US$ Mn)
TABLE 699 Rest of Africa Rare Disease Genetic Testing Market, By Diagnostic Testing, 2023-2030 (US$ Mn)
TABLE 700 Rest of Africa Rare Disease Genetic Testing Market, By Preimplantation Genetic Testing (PGT), 2017-2022 (US$ Mn)
TABLE 701 Rest of Africa Rare Disease Genetic Testing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 702 Rest of Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2017-2022 (US$ Mn)
TABLE 703 Rest of Africa Rare Disease Genetic Testing Market, By Direct-to-Consumer (DTC) Genetic Testing, 2023-2030 (US$ Mn)
TABLE 704 Rest of Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2017-2022 (US$ Mn)
TABLE 705 Rest of Africa Rare Disease Genetic Testing Market, By Technological Platforms, 2023-2030 (US$ Mn)
TABLE 706 Rest of Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2017-2022 (US$ Mn)
TABLE 707 Rest of Africa Rare Disease Genetic Testing Market, By Bioinformatics and Data Analysis, By Region, 2023-2030 (US$ Mn)
TABLE 708 Rest of Africa Rare Disease Genetic Testing Market, By End-User, 2017-2022 (US$ Mn)